TY - JOUR
T1 - Pre-Emptive Avoidance Strategy (P.E.A.S.)-addressing allergic contact dermatitis in pediatric populations
AU - Hill, Hannah
AU - Goldenberg, Alina
AU - Golkar, Linda
AU - Beck, Kristyn
AU - Williams, Judith
AU - Jacob, Sharon E.
N1 - Publisher Copyright:
© 2016 Informa UK Limited.
PY - 2016/5/3
Y1 - 2016/5/3
N2 - Pediatric allergic contact dermatitis (ACD) has been increasingly recognized in the United States. Reported rates of positive patch tests in children referred for suspected ACD range between 27 and 95.6%. Many young children are becoming sensitized to contact allergens found in personal hygiene products. We reviewed five recent pediatric patch test studies to determine the top allergens associated with this source of ACD in children. The top ten allergens were neomycin, balsam of Peru, fragrance mix, lanolin, cocamidopropylbetaine, formaldehyde, corticosteroids, methylchlorisothiazolinone (MCI)/methylisothiazolinone (MI), propylene glycol, and benzalkonium chloride. We estimate that one third of children suffering from ACD could potentially benefit from a pre-emptive avoidance strategy (P.E.A.S.) of the stated top 10 allergens.
AB - Pediatric allergic contact dermatitis (ACD) has been increasingly recognized in the United States. Reported rates of positive patch tests in children referred for suspected ACD range between 27 and 95.6%. Many young children are becoming sensitized to contact allergens found in personal hygiene products. We reviewed five recent pediatric patch test studies to determine the top allergens associated with this source of ACD in children. The top ten allergens were neomycin, balsam of Peru, fragrance mix, lanolin, cocamidopropylbetaine, formaldehyde, corticosteroids, methylchlorisothiazolinone (MCI)/methylisothiazolinone (MI), propylene glycol, and benzalkonium chloride. We estimate that one third of children suffering from ACD could potentially benefit from a pre-emptive avoidance strategy (P.E.A.S.) of the stated top 10 allergens.
KW - Allergy
KW - allergen
KW - contact dermatitis
KW - dermatitis
KW - pediatric
KW - pre-emptive avoidance strategy
UR - http://www.scopus.com/inward/record.url?scp=84961216864&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84961216864&partnerID=8YFLogxK
U2 - 10.1586/1744666X.2016.1142373
DO - 10.1586/1744666X.2016.1142373
M3 - Review article
C2 - 26764601
SN - 1744-666X
VL - 12
SP - 551
EP - 561
JO - Expert Review of Clinical Immunology
JF - Expert Review of Clinical Immunology
IS - 5
ER -